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Abstract
In pregnancies achieved after egg donation (ED) tolerance towards a completely allogeneic fetus is mediated by several
complex immunoregulatory mechanisms, of which numerous aspects are still unknown. A distinct lesion not described
previously in the literature, was repeatedly found in the chorionic plate in a substantial portion of placentas from ED
pregnancies, but never in placentas from normal term pregnancies. The aim of this study was to assess its origin and its
cellular composition. The relation between the lesion, the clinical and histological parameters were assessed. In addition we
investigated the relation with the number of HLA-mismatches and KIR genotype of mother and child. In ten out of twenty-
six (38.5%) placentas from ED pregnancies an inflammatory lesion was present in the chorionic plate. A significantly lower
incidence of pre-eclampsia was found in the group with the lesion; 0% versus 45.5%. A significant relation was found
between this lesion and the presence of intervillositis, chronic deciduitis, presence of plasma cells and fibrin deposition in
the decidua. Fluorescent in situ hybridisation with X/Y-chromosome probes showed that the majority of cells present in the
lesion are of maternal origin. The expression of the macrophage marker CD14+ and of the type 2 macrophage (M2) marker
CD163+ was significantly higher in the lesion. The incidence of a fetal HLA-C2 genotype was significantly higher in cases
with a lesion compared to the group without the lesion. In conclusion, a striking relationship was observed between the
presence of a not previously described inflammatory lesion in the chorionic plate and the absence of pre-eclampsia in ED
pregnancies. The lesion consists of mainly maternal cells with a higher expression of the macrophage marker CD14+ and the
M2 marker CD163+. These findings suggest a protective immune mechanism which might contribute to the prevention of
severe clinical complications like pre-eclampsia.
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Introduction
During pregnancy the maternal immune system does not reject
the fetus even though allogeneic paternal HLA antigens of the
fetus are recognized by the maternal immune system. Tolerance to
the semi-allogeneic fetus is mediated by several complex
immunoregulatory mechanisms, of which numerous aspects are
still poorly understood [1]. Immunologically even more intriguing
are pregnancies achieved after egg donation (ED) in which the
maternal immune system must maintain tolerance towards an
often completely allogeneic fetus.
The increased risk of pre-eclampsia [2,3] and a higher incidence
of placental pathological lesions, such as chronic villitis of
unknown etiology, chronic deciduitis and massive chronic
intervillositis, found in ED cases is probably based on a
dysregulation of the local immune response at the fetal-maternal
interface [4,5].
Decidual macrophages are thought to play an important
regulatory role at the fetal-maternal interface. Decidual macro-
phages from normal pregnancies were molecularly characterized
as M2 phenotype [6]. M2 macrophages are involved in tissue
remodeling and inhibit inflammation [7] and therefore believed to
be important for the maintenance of the tolerance to the non-self
semi-allogeneic fetus [8].
The expression of Human leukocyte antigen-C (HLA-C) on the
extravillous trophoblast is considered to be of critical importance
in the acceptance of the fetus. HLA-C can interact with activating
KIR receptors on uterine natural killer (uNK) cells and thereby
modulate the immune function of these uNK cells. Hiby showed
that certain combinations of fetal HLA-C, especially HLA-C2 and
maternal KIR genotype (AA) were at a higher risk of developing
pre-eclampsia [9,10] .The KIR AA genotype is supposed to be
associated with inhibition of uNK cell function.
Several studies in human term pregnancies and murine studies
have shown an important role for T cells in specific immune
tolerance to fetal alloantigens [11–13]. In addition, there is
evidence that decidual T cells can specifically be activated by fetal
HLA-C [14]. In uncomplicated pregnancies we have previously
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C mismatches and the induction of functional regulatory T cells
[14].
Gundosan et al [15] observed an inflammatory infiltrate of T-
cells and uNK cells in the decidua of ED pregnancies. A
resemblance with host versus graft disease is suggested in which
a maternal alloimmune reaction is triggered by fetal cells present
at the human fetal–maternal interface.
In the current study we investigated the histopathological
features of placentas from a large group of ED pregnancies.
During histological evaluation of the chorionic plate a distinct
lesion of inflammatory cells was repeatedly found in a substantial
proportion of placentas from ED pregnancies but never in
placentas from normal term pregnancies. To our knowledge such
a lesion has not been described previously in the literature.
In this study we characterize the origin and nature of the
cellular infiltrate in the lesion. In addition its association with the
number of HLA mismatches, KIR genotypes of mother and child
was investigated. Further studies on histological and clinical
parameters suggest that this lesion may reflect a protective
immune mechanism of the mother’s immune system towards the
completely allogeneic fetus.
Methods
Patients
Prospectively we studied pregnancies from women conceived by
egg cell donation. From all pregnancies paired samples of decidua
basalis, decidua parietalis and heparinised maternal peripheral
blood and heparinised cord blood were obtained. Maternal
peripheral blood samples were obtained either directly before or
directly after delivery. Data of medical records of all patients were
reviewed. Pre-eclampsia was defined according to the classification
of International Society for the Study of Hypertension in
Pregnancy [16] as new hypertension (systolic bloodpressure of
$140 mmHg and/or diastolic bloodpressure of $90 mmHg) after
20 weeks of gestational age in combination with proteinuria
($300 mg in 24 hr). Signed written informed consent was
obtained from all women, and the study received approval by
the Leiden University Medical Center Ethics Committee (P02-
200).
Histology
After delivery either by caesarean section or vaginally, all
placentas (n=26) were macroscopically examined according to a
standard protocol. Tissue samples were taken from the basal plate
of the placenta and the fetal membranes, with a minimum of three
pre-defined locations: centrally, in the periphery and one in
between these locations. Tissue samples were fixed in 4% formalin
and then routinely processed to paraffin blocks. Serial sections
(4 mm thick) were cut on coated slides and dried overnight at
37uC.
The tissue specimens were stained with hematoxylin and eosin
(H&E) and examined blind by a single pathologist (DR) and scored
for pathological signs of chorioamnionitis [17], chronic villitis,
intervillositis, chronic deciduitis, ischemic changes or infarction,
perivillous fibrin deposition [18], increased syncytial knots and
accelerated maturity.
Fluorescent in situ hybridisation (FISH)
In order to determine the origin of the cells in the chorionic
plate we performed fluorescent in situ hybridization (FISH) to
visualize the X- and Y-chromosome in placentas derived from a
male neonate with and without the lesion. This analysis was
performed with the assumption that the chorionic plate of a
placenta from a male neonate would be completely consist of male
cells.
Serial sections were cut from three ED placentas with the
chorionic plate lesion and from three ED placentas without the
lesion, all from male neonates. Slides were deparaffinized and
hydrated via graded alcohols to distilled water at 37uC. Heat
induced antigen-retrieval was performed for 60 minutes at 80uC
with citrate buffer followed by rinsing in distilled water at 37uC,
three times in 26SSC at 37uC and in PBS at 37uC. Slides were
then treated with 0.05% pepsin in 0.01 M HCl at 37uC for
10 minutes, washed in PBS, and finally dehydrated in graded
ethanol series up to ethanol 100% and air-dried. The slides were
incubated with CEP X/Y DNA probe (Vysis/Abbott Molecular)
and denaturation was performed at 80uC for 4 minutes, followed
by overnight hybridization at 37uC in a moist chamber. After
hybridization, slides were rinsed three times in 26 SSC/0.1%
Tween at 37uC, three times in 0.16 SSC at 60uC and once in
TNT buffer at room temperature. Subsequently, slides were
dehydrated in ethanol series up to ethanol 100%, air-dried and
mounted with Vectashield anti-fade reagent containing
50 mgm l
21 DAPI (49,6-diamidino-2-phenylindole) for counter-
staining of DNA.
Immunohistochemistry
To determine the cellular composition of the infiltrate,
immunohistochemistry was performed to analyze a broad panel
of membranous receptors and intra-cellular markers of immune
cells. Slides were deparaffinized and hydrated via graded alcohols
to distilled water. After endogenous peroxidase activity was
blocked for 20 minutes by 3% H2O2 in water, immunohisto-
chemical staining was performed using the manufactures protocol.
Briefly, heat-induced antigen-retrieval was performed for 20 min-
utes in a microwave. The slides were cooled down for 20 minutes
followed by wash steps with first water and secondly PBS. The
sections were incubated for one hour with primary antibody in the
pre-determined dilutions in PBS with 1% BSA as described in
Table 1. As a control the primary antibody was replaced by PBS
with 1% BSA. After washing three times in PBS the slides were
incubated for 30 minutes with Envision, followed by another
washing step and incubation for 5 minutes with diaminobenzidine
(DAB+, DAKO cytomation). Stained specimens were counter-
stained with haematoxylin (Sigma).
Tissue slides were reviewed and scored by two independent
observers (DS and GS). In areas with chorionic plate lesion and in
the control placentas without the lesion present deposition of
immunohistochemical stainings was scored semi-quantitatively.
On a 4 point scale, staining intensity was graded from no staining
deposition (1) to low focal deposition (2), moderate focal deposition
(3) to diffuse deposition (4).
HLA and KIR genotyping
All mothers and children were molecularly typed at low
resolution level for the loci HLA-A, HLA-B, HLA-C, HLADRB1
and HLA-DQB1 using the Sequence Specific Oligonucleotides
(SSO) PCR technique as described previously [14]. HLA typing
was performed at the national reference laboratory for histocom-
patibility testing (LUMC, The Netherlands). The number of fetal–
maternal HLA matches and mismatches was determined on the
basis of the 2-digit DNA typing. The HLA-C1 and HLA-C2 group
of both mother and child was established using the HLA-C low
resolution DNA typing for the presence of ser77asn80 (C1) and
asn77lys80 (C2) in the DNA sequence [19]. The number of C1
Chorionic Plate Lesion
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self’) was determined.
To characterize the KIR genes of all mothers and children we
performed a real time PCR method that identifies the presence or
absence of 16 KIR genes, as previously described [20]. The
haplotype A or B group of mother and child was established on
basis of the number of activating and inhibitory KIR genes present
[19]. Group A haplotypes possess a single activating gene,
KIR2DS4, as well as four inhibitory genes encoding proteins
representing the main HLA class I specificities, KIR2DL1,
KIR2DL3, KIR3DL1 and KIR3DL2. Group B haplotypes
possess different combinations of KIR2DL5, KIR2DS1,
KIR2DS2, KIR2DS3, KIR2DS5 and KIR3DS1 genes. The
HLA-C1 and HLA-C2 group of both mother and child were
analyzed in the context of the group A and B haplotype of the KIR
genes.
Statistics
Categorical variables were compared using Fisher’s exact test or
the chi-square test. To determine differences between two groups
with numerical data we used the one-sample T test. All statistical
analyses were performed using SPSS software, version 17.0. P
values less than 0.05 were considered significant.
Results
Patient characteristics
Patient characteristics of the two ED groups of pregnancies,
those with and without the lesion in the chorionic plate are listed
in Table 2. A significantly lower incidence of pre-eclampsia was
found in the group with the lesion in the chorionic plate, 0%
versus 45.5% (p=0.03). There were no significant differences in
the other maternal parameters. The average maternal age was
respectively 40,3 years and 40 years in the group with and without
the lesion in the chorionic plate. No significant differences were
found in gestational age and fetal clinical outcomes between the
two groups. There were no clinical symptoms of infection in
mother and neonates during pregnancy, delivery or postpartum.
Histopathology
In ten out of twenty-six placentas (38.5%) a lesion was present in
the chorionic plate. The lesion was present in several locations in
Table 1. Antibodies.
Epitope Antigen retrieval Primary antibody, dilution and source Secondary antibody
CD45 None Mouse mAB, 1:100, Dako # M0701 Anti-Mouse Envision*
CD3 Tris/EDTA
{ Rabbit IgG, 1:150, Abcam # ab828 Anti-Rabbit Envision
CD4 Tris/EDTA Mouse mAB, 1:50, Novocastra, clone 1F6 Anti-Mouse Envision
CD8 Tris/EDTA Mouse mAB, 1:100, Novocastra, clone 4b11 Anti-Mouse Envision
CD56 Tris/EDTA Mouse mAB, 1:30, Dako, clone 123C3 Anti-Mouse Envision
CD14 Tris/EDTA Mouse mAB, 1:200, Novocastra, clone 7 Anti-Mouse Envision
CD163 Tris/EDTA Mouse mAB, 1:20, Abcam, clone 10D6 Anti-Mouse Envision
Cytokeratin-7 Tris/EDTA Mouse mAB, 1:2000, Dako, clone OV-TL 12/30 Anti-Mouse Envision
SMA Tris/EDTA Mouse mAB, 1:500, Progen, clone ASM-1 Anti-Mouse Envision
{Tris/EDTA: 0.1 mol/L (pH 9.0).
*Envision: Dako, North America Inc, USA (anti-mouse and anti-rabbit Envision HRP).
doi:10.1371/journal.pone.0032347.t001
Table 2. Patient characteristics of the two ED groups of pregnancies, those with and without the lesion in the chorionic plate.
Clinical Parameters No lesion present Lesion present P
Mother Age (years) 40.0 (27–49) 40.3 (35–45) 0.91
Gravidity 2.2 (1–7) 2.7 (1–5) 0.50
Parity 0.3 (0–2) 0.7 (0–2) 0.21
Miscarriages 0.6 (0–3) 0.6 (0–1) 0.98
Highest diastole (mmHG) 87.3 (70–105) 78.4 (60–90) 0.07
Percentage Pre-eclampsia 45.5% 0% 0.03*
Delivery Gestational age (weeks) 38+2 (33–42) 37+6 (27–41) 0.78
Percentage Caesarian
section
63.6% 66.7% 0.63
Child Percentage Male Gender 50% 60% 0.46
Birth weight (gram) 2744 (1433–4100) 3171 (1028–4130) 0.26
Placental weight (gram) 550 (326–880) 592 (360–835) 0.58
Average (range).
*p,0.05.
doi:10.1371/journal.pone.0032347.t002
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PLoS ONE | www.plosone.org 3 March 2012 | Volume 7 | Issue 3 | e32347Figure 1. Significant relationship between the presence of the lesion in the chorionic plate and histological parameters. A. Bar graph
of placental histological scores in percentage. B. Incidence of histological parameters in placentas with and without the lesion in the chorionic plate.
A significant relationship was found between the presence of the lesion in the chorionic plate and intervillositis and histological parameters in the
decidua; including chronic deciduitis, presence of plasma cells in the decidua and fibrin deposition in the decidua. Number (percentage) Fisher’s
exact test. * p,0.05 ** p,0.01.
doi:10.1371/journal.pone.0032347.g001
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infiltrate involving the entire chorionic plate from the amniotic
epithelium towards the intervillous space. We found an associated
myxomatous change in the mesoderm of the plate and
inflammatory cells within the plate and the subchorionic space.
It was restricted to the chorionic plate and not on the chorion
laeve. In the fetal membranes were no signs present of the lesion.
No significant association was found between this lesion and the
presence of chorio-amnionitis (Figure 1A–B). A significant
relationship was found between the presence of the lesion in the
chorionic plate and intervillositis (p=0.018). Remarkably a
significant association was found between the presence of this
lesion and histological parameters in the decidua, including
chronic deciduitis (p=0.003), presence of plasma cells in the
decidua (p=0.002) and fibrin deposition in the decidua (p=0.007)
(Figure 1A–B). There was no significant association between the
presence of the lesion in the chorionic plate and villitis of unknown
origin (p=0.063), or in signs of abnormal maturation.
Origin of the infiltrate
The majority of cells present in the lesion in the chorionic plate
comprise of cells with two X-chromosomes as detected by FISH
analysis, which is compatible with an infiltrate by maternal cells.
The maternal cell infiltrate was extended within the boundaries of
the histological lesion.
In contrast we found in the chorionic plate of placentas without
the lesion present a predominance of male XY-cells (Figure 2).
Cellular composition of the infiltrate
Results of the immunohistochemical stainings are depicted in
Figure 3. The expression of the macrophage markers CD14+
(p=0.018) and macrophage scavenger receptor CD163+
(p=0.018) was significantly higher in the group with the lesion
present.
The T-cell markers CD3+, CD4+ and CD8+ showed no
significant differences between the two groups. No correlation was
found between the presence of the lesion and respectively the uNK
cell marker CD56+ (Figure 3), the leukocyte marker CD45+ (data
not shown), the fibroblast marker smooth muscle actin (data not
shown) and the trophoblast marker Cytokeratine-7 (Figure 3).
HLA+KIR typing
No correlations were found between the number of classical
HLA-A, HLA-B, HLA-C, HLA-DRB1 and HLA-DQB1 mis-
matches between mother and child, and the presence of the lesion
in the chorionic plate.
When the lesion in the chorionic plate is present, the incidence
of a fetal HLA-C2 genotype is significantly higher (p=0.037)
compared to the group without the lesion (Table 3). No
correlations were found between the HLA-C1 genotype of both
Figure 2. Majority of cells present in the lesion in the chorionic
plate comprise of maternal cells. Fluorescent in situ hybridization
of the X- and Y-chromosome in placentas derived from a male neonate,
respectively red and green. Nuclei are stained blue. In the left panel
(A,C) slides with no lesion present and in the right panel (B,D) slides
with a lesion in the chorionic plate present. The lower panel (C,D) shows
a magnification from the pictures in the upper panel. In the slides with
lesion present all nuclei contain two red X-chromosomes.
doi:10.1371/journal.pone.0032347.g002
Figure 3. Higher expression of the macrophage marker CD14+,
the M2 marker CD163+ and DC-Sign in the lesion. Immunohis-
tochemical stainings of egg donation placentas. In the left panel serial
slides with no lesion present and in the right panel serial slides with the
lesion present in the chorionic plate. From top to bottom are depicted
the stainings H&E, Cytokeratin-7, CD56+, CD8+, CD14+ and CD163+.W e
observed a higher expression of the macrophage marker CD14+ and
the M2 marker CD163+.
doi:10.1371/journal.pone.0032347.g003
Chorionic Plate Lesion
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HLA-C2 genotype is combined with the maternal haplotype KIR
B 66.7% of this group has the lesion present in the chorionic plate
(Table 4). However this difference is statistically not significant. No
other fetal HLA-C and maternal KIR haplotypes showed such a
difference (Table 5).
Discussion
We observed a striking relationship between the presence of a
not previously described lesion in the chorionic plate and the
absence of pre-eclampsia, a relatively common complication in
ED pregnancies [3]. In order to characterize cells possibly
involved in the development of the lesion, we performed
immunohistochemistry with several markers to phenotype the
cells and in situ hybridization to determine their origin.
This report suggests an immunological protective mechanism in
the chorionic plate of maternal cells directed against paternal
antigens present in the fetal tissue. Intervillositis and several
pathological parameters in the decidua are associated with this
chronic lesion. Strikingly this lesion is absent in any of the cases
complicated with pre-eclampsia. It is likely that this immunological
activation might be a crucial factor in protection against pre-
eclampsia .
Both the general macrophage marker CD14+ and the specific
M2 marker CD163 were significantly upregulated in the placentas
with the lesion. No definite relationship was found between the
presence of the lesion in the chorionic plate and the expression of
T-cell markers (CD3, CD4, CD8), NK-cell marker (CD56),
trophoblast marker (cytokeratine-7) and myofibroblast expression
(SMA). When the lesion in the chorionic plate is present then the
fetal HLA-C2 genotype is significantly higher compared to the
group without the lesion. Together these findings suggest a
prominent role for an immunosuppressive macrophage subset in
uneventful ED pregnancies,
Possibly the lesion in the chorionic plate is a distinct reaction of
the mother’s immune system to the often complete allogeneic
fetus. The chorionic plate is never described before in normal
physiological circumstances as a site of direct contact between
maternal and fetal cells.
Gundogan et al [15] observed a lesion of chronic deciduitis with
increased infiltration of CD4+ T-cells and CD56+ natural killer
cells in the basal plate in egg donation pregnancies. No apparent
involvement of macrophages were described in their studies. In
contrast to Gundogan et al [15] we describe here a lesion found
only in a group ED placentas infiltrated with macrophages at a
different location, the chorionic plate. This lesion in the chorionic
plate is associated with characteristic histo-pathological findings in
the decidua.
The lesion was repeatedly found in the chorionic plate in a
substantial portion of placentas from ED pregnancies, but never in
placentas from non-egg donation pregnancies. We examined a
group of 29 non-egg cell donation placentas of uncomplicated
term pregnancies and a group of 25 non-egg cell donation
placentas of pregnancies complicated by pre-eclampsia before 34
weeks of gestation and investigated the placentas for histological
signs of a lesion in the chorionic plate. In neither of these two
groups did we find a placenta with a lesion in the chorionic plate
(data not shown).
Interestingly no effect on birth weight and neonatal outcomes
were found between the group with and without the chorionic
plate and lesion, regardless of the incidence of pre-eclampsia.
More remarkable is our finding that pre-eclampsia only occurs in
the group without the immunological lesion in the chorionic plate,
regardless of the maternal age. Advanced maternal age is a well
known risk factor for several pregnancy complications including
pre-eclampsia [21]. Since increasing maternal age is nowadays the
number one reason for ED, you would expect an association
between ED pregnancies and pre-eclampsia. But even corrected
for maternal age, pregnancies conceived with ED is an
independent risk factor for pre-eclampsia.
The hypothesis that an unidentified cause of pre-eclampsia
might include excessive or atypical maternal immune response to
trophoblast is widely believed nowadays [22]. This would make
pre-eclampsia a disease of failed interaction between two
genetically different organisms [23]. Several genetic aspects have
been described with a higher risk of pre-eclampsia. For example a
limited sperm exposure with the same partner before conception
increases the risk for pre-eclampsia [24,25].
Paternal part of inheritance of the HLA could be an important
factor of the maternal immune response to the fetal trophoblast.
The trophoblast expresses only the HLA-C and HLA-G on its
surface [26]. HLA-C antigens are the main ligands for the
inhibitory KIRs, the specificity of the interaction being determined
by a genetic polymorphism at positions 77 and 80.
Our study shows that the absence of a lesion in the chorionic
plate is associated with pre-eclampsia, while there is a significantly
lower incidence of the HLA-C2 genotype in the fetus. Hiby et all
described that in conditions associated with defective placentation,
mothers with a KIR AA genotype seem to more at risk when this
Table 4. Combination of fetal HLA-C2 and maternal KIR B, in comparison with the presence of the lesion in the chorionic plate.
Combination of fetal HLA-C2 genes with maternal KIR B haplotype No lesion present Lesion present
No combination of fetal HLA-C2/ maternal KIR B 12 75.0% 4 25.0%
Combination of fetal HLA-C2/ maternal KIR B 3 33.3% 6 66.7%
Number (percentage).
Fisher exact (2-sided) p=0.087.
doi:10.1371/journal.pone.0032347.t004
Table 3. Number of fetal HLA-C2 genes present, in
combination with the presence of the lesion in the chorionic
plate.
Fetal HLA-C2 genes No lesion present Lesion present
No fetal HLA-C2 genes 9 90.0% 1 10.0%
One or two fetal HLA-C2
genes
7 43.8% 9 56.3%
Number (percentage).
Fisher exact (2-sided) p=0.037.
doi:10.1371/journal.pone.0032347.t003
Chorionic Plate Lesion
PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e32347genotype is combined with fetal HLA- C2 [9,10] . This effect was
true even if mothers had HLA-C2, indicating that neither non-self
interactions nor missing self discrimination was a contributing
factor. Moreover they described the protective effect of the
presence of a KIR B region which reached significance when the
fetus carried a HLA-C2 group [10]. This is consistent with our
data that 66.7% of the group in which fetal HLA-C2 genotype is
combined with the maternal haplotype KIR B has the protective
lesion present in the chorionic plate. The fact that this difference is
not statistically could be due to the small number of patients in this
study.
However, our analysis was restricted to ED pregnancies that
resulted in live births, which may have underscored the incidence
of detrimental immune reactions in ED pregnancies resulting in
spontaneous abortion.
This newly described lesion is probably not a separate entity,
but part of a broad spectrum of histological pathology induced by
the maternal immune system to the completely allogeneic fetus.
Our results raise the possibility that the maternal immune system
may exert a protective effect in preventing clinical complications
like pre-eclampsia.
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